Vitamin E-based nanomedicines for anti-cancer drug delivery

Plapied, 2011, Fate of polymeric nanocarriers for oral drug delivery, Curr. Opin. Colloid Interface Sci., 16, 228, 10.1016/j.cocis.2010.12.005

Farokhzad, 2009, Impact of nanotechnology on drug delivery, ACS Nano, 3, 16, 10.1021/nn900002m

Youan, 2008, Impact of nanoscience and nanotechnology on controlled drug delivery, Nanomedicine, 3, 401, 10.2217/17435889.3.4.401

Singh, 2009, Nanoparticle-based targeted drug delivery, Exp. Mol. Pathol., 86, 215, 10.1016/j.yexmp.2008.12.004

Hall, 2007, Characterization of nanoparticles for therapeutics, Nanomedicine, 2, 789, 10.2217/17435889.2.6.789

Kumari, 2010, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf. B Biointerfaces, 75, 1, 10.1016/j.colsurfb.2009.09.001

Steichen, 2012, A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics, Eur. J. Pharm. Sci., 48, 416, 10.1016/j.ejps.2012.12.006

Danhier, 2010, To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery, J. Control. Release, 148, 135, 10.1016/j.jconrel.2010.08.027

Bamrungsap, 2012, Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system, Nanomedicine, 7, 1253, 10.2217/nnm.12.87

Bharali, 2009, Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers, Int. J. Nanomedicine, 4, 1

Puri, 2009, Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic, Crit. Rev. Ther. Drug Carrier Syst., 26, 523, 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10

Zhang, 2012, Vitamin E TPGS as a molecular biomaterial for drug delivery, Biomaterials, 33, 4889, 10.1016/j.biomaterials.2012.03.046

Vaidya, 2011, Bioconjugation of polymers: a novel platform for targeted drug delivery, Curr. Pharm. Des., 17, 1108, 10.2174/138161211795656873

Vijayakumar, 2013, Copolymers of poly(lactic acid) and d-alpha-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy, Expert Opin. Drug Deliv., 10, 529, 10.1517/17425247.2013.758632

Petros, 2010, Strategies in the design of nanoparticles for therapeutic applications, Nat. Rev. Drug Discov., 9, 615, 10.1038/nrd2591

Davis, 2008, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat. Rev. Drug Discov., 7, 771, 10.1038/nrd2614

Jain, 2010, Delivering nanomedicine to solid tumors, Nat. Rev. Clin. Oncol., 7, 653, 10.1038/nrclinonc.2010.139

Torchilin, 2010, Passive and active drug targeting: drug delivery to tumors as an example, Handb. Exp. Pharmacol., 3, 10.1007/978-3-642-00477-3_1

Mustacich, 2007, Vitamin E, Vitam. Horm., 76, 1, 10.1016/S0083-6729(07)76001-6

Wong, 2012, Tocotrienol research: past into present, Nutr. Rev., 70, 483, 10.1111/j.1753-4887.2012.00512.x

Guo, 2013, The applications of Vitamin E TPGS in drug delivery, Eur. J. Pharm. Sci., 49, 175, 10.1016/j.ejps.2013.02.006

Constantinides, 2006, Advances in the use of tocols as drug delivery vehicles, Pharm. Res., 23, 243, 10.1007/s11095-005-9262-9

Kline, 2007, Vitamin E and cancer, Vitam. Horm., 76, 435, 10.1016/S0083-6729(07)76017-X

Combs, 2012, Vitamin E, 181

Zingg, 2007, Vitamin E: an overview of major research directions, Mol. Aspects Med., 28, 400, 10.1016/j.mam.2007.05.004

Atkinson, 2010, The location and behavior of alpha-tocopherol in membranes, Mol. Nutr. Food Res., 54, 641, 10.1002/mnfr.200900439

Brigelius-Flohe, 2006, Bioactivity of vitamin E, Nutr. Res. Rev., 19, 174, 10.1017/S0954422407202938

Frank, 2005, Beyond vitamin E supplementation: an alternative strategy to improve vitamin E status, J. Plant Physiol., 162, 834, 10.1016/j.jplph.2005.04.017

Azzi, 2002, Non-antioxidant molecular functions of alpha-tocopherol (vitamin E), FEBS Lett., 519, 8, 10.1016/S0014-5793(02)02706-0

Brigelius-Flohe, 2002, The European perspective on vitamin E: current knowledge and future research, Am. J. Clin. Nutr., 76, 703, 10.1093/ajcn/76.4.703

Brigelius-Flohe, 2009, Vitamin E: the shrew waiting to be tamed, Free Radic. Biol. Med., 46, 543, 10.1016/j.freeradbiomed.2008.12.007

Prasad, 2003, Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review, J. Am. Coll. Nutr., 22, 108, 10.1080/07315724.2003.10719283

Kline, 2004, Vitamin E and breast cancer, J. Nutr., 134, 3458S, 10.1093/jn/134.12.3458S

Constantinou, 2008, Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs, Int. J. Cancer, 123, 739, 10.1002/ijc.23689

Dong, 2009, Anticancer mechanisms of vitamin e succinate, Chin. J. Cancer, 28, 1, 10.5732/cjc.008.10182

Zingg, 2007, Modulation of signal transduction by vitamin E, Mol. Aspects Med., 28, 481, 10.1016/j.mam.2006.12.009

Dong, 2011, Mitochondrial targeting of alpha-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy, Free Radic. Biol. Med., 50, 1546, 10.1016/j.freeradbiomed.2011.02.032

Anbharasi, 2010, Doxorubicin conjugated to d-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy, J. Biomed. Mater. Res. A, 94, 730, 10.1002/jbm.a.32734

Wang, 2006, Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate, Mol. Nutr. Food Res., 50, 675, 10.1002/mnfr.200500267

Genentech website

Malafa, 2000, Vitamin E succinate promotes breast cancer tumor dormancy, J. Surg. Res., 93, 163, 10.1006/jsre.2000.5948

Malafa, 2002, Vitamin E inhibits melanoma growth in mice, Surgery, 131, 85, 10.1067/msy.2002.119191

Barnett, 2002, Vitamin E succinate inhibits colon cancer liver metastases, J. Surg. Res., 106, 292, 10.1006/jsre.2002.6466

Malafa, 2002, Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate, Ann. Surg. Oncol., 9, 1023, 10.1007/BF02574523

Neuzil, 2001, Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements, FASEB J., 15, 403, 10.1096/fj.00-0251com

Stapelberg, 2005, Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress, J. Biol. Chem., 280, 25369, 10.1074/jbc.M414498200

Wu, 2001, Inhibitory effects of RRR-alpha-tocopheryl succinate on benzo(a)pyrene (B(a)P)-induced forestomach carcinogenesis in female mice, World J. Gastroenterol., 7, 60, 10.3748/wjg.v7.i1.60

Ramanathapuram, 2006, Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines, Cancer Immunol. Immunother., 55, 166, 10.1007/s00262-005-0016-7

Collnot, 2006, Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers, J. Control. Release, 111, 35, 10.1016/j.jconrel.2005.11.005

Bansal, 2009, Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation, Drug Discov. Today, 14, 1067, 10.1016/j.drudis.2009.07.010

Collnot, 2007, Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity, Mol. Pharm., 4, 465, 10.1021/mp060121r

Youk, 2005, Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol, J. Control. Release, 107, 43, 10.1016/j.jconrel.2005.05.014

Yi, 2005, A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution, Pharm. Res., 22, 200, 10.1007/s11095-004-1187-1

Noh, 2011, Tocopheryl oligochitosan-based self assembling oligomersomes for siRNA delivery, Biomaterials, 32, 849, 10.1016/j.biomaterials.2010.09.027

Liang, 2012, Alpha-tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations, Int. J. Pharm., 423, 480, 10.1016/j.ijpharm.2011.12.004

Tao, 2013, Nano-formulation of paclitaxel by vitamin E succinate functionalized pluronic micelles for enhanced encapsulation, stability and cytotoxicity, Colloids Surf. B Biointerfaces, 102, 604, 10.1016/j.colsurfb.2012.08.062

Saxena, 2012, Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer, Int. J. Nanomedicine, 7, 713

Zhao, 2011, Formulation and in vitro evaluation of quercetin loaded polymeric micelles composed of pluronic P123 and d-α-tocopheryl polyethylene glycol succinate, J. Biomed. Nanotechnol., 7, 358, 10.1166/jbn.2011.1298

Gao, 2008, Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin, Colloids Surf. B Biointerfaces, 64, 194, 10.1016/j.colsurfb.2008.01.021

Gill, 2012, Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines, Eur. J. Pharm. Sci., 46, 64, 10.1016/j.ejps.2012.02.010

Wang, 2012, Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance, Biomaterials, 33, 6877, 10.1016/j.biomaterials.2012.06.019

Mi, 2011, Formulation of docetaxel by folic acid-conjugated d-alpha-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2K)) micelles for targeted and synergistic chemotherapy, Biomaterials, 32, 4058, 10.1016/j.biomaterials.2011.02.022

Muthu, 2012, Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots, Biomaterials, 33, 3494, 10.1016/j.biomaterials.2012.01.036

Muthu, 2011, Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells, Int. J. Pharm., 421, 332, 10.1016/j.ijpharm.2011.09.045

Wang, 2012, Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin, Int. J. Nanomedicine, 7, 2325

Yu, 2012, Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma, Biomaterials, 33, 1808, 10.1016/j.biomaterials.2011.10.085

Raju, 2013, Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel, Expert Opin. Drug Deliv., 6, 747, 10.1517/17425247.2013.777425

Shen, 2012, Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer, Biomaterials, 33, 8613, 10.1016/j.biomaterials.2012.08.007

Shen, 2013, Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles, Biomaterials, 34, 1581, 10.1016/j.biomaterials.2012.10.057

Liu, 2010, Paclitaxel nanocrystals for overcoming multidrug resistance in cancer, Mol. Pharm., 7, 863, 10.1021/mp100012s

Shieh, 2011, Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells, J. Control. Release, 152, 418, 10.1016/j.jconrel.2011.03.017

Song, 2011, Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery, Colloids Surf. B Biointerfaces, 87, 454, 10.1016/j.colsurfb.2011.06.009

Zhang, 2007, Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery, Biomaterials, 28, 1889, 10.1016/j.biomaterials.2006.12.018

Sun, 2009, Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel, Nanomedicine, 4, 431, 10.2217/nnm.09.17

Cao, 2008, Doxorubicin conjugated to d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation, Biomaterials, 29, 3856, 10.1016/j.biomaterials.2008.05.016

Mi, 2012, Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects, Int. J. Pharm., 438, 98, 10.1016/j.ijpharm.2012.08.038

Mi, 2013, Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer, J. Control. Release, 169, 185, 10.1016/j.jconrel.2013.01.035

Nielsen, 2001, The effect of alpha-tocopherol on the in vitro solubilisation of lipophilic drugs, Int. J. Pharm., 222, 217, 10.1016/S0378-5173(01)00701-3

Constantinides, 2004, A DFT study of the ground state multiplicities of linear vs angular polyheteroacenes, J. Am. Chem. Soc., 126, 16232, 10.1021/ja045006t

Chan, 2007, Review on Medusa:a polymer-based sustained release technology for protein and peptide drugs, Expert Opin. Drug Deliv., 4, 441, 10.1517/17425247.4.4.441

Zhang, 2007

Duhem, 2013, Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity, Bioconjug. Chem., 25, 72, 10.1021/bc400326y

Eastman

Collnot, 2010, Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access, Mol. Pharm., 7, 642, 10.1021/mp900191s

OncoGenex Pharmaceuticals website

Medicalnewstoday website

Varma, 2005, Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo, Eur. J. Pharm. Sci., 25, 445, 10.1016/j.ejps.2005.04.003

Zhang, 2012, Influence of vitamin E tocopherol polyethylene glycol succinate 1000 on intestinal absorption of icariside II, Pharmazie, 67, 59

Muthu, 2012, Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats, Nanomedicine, 7, 353, 10.2217/nnm.11.111

Rachmawati, 2013, Development of curcumin nanocrystal: physical aspects, J. Pharm. Sci., 102, 204, 10.1002/jps.23335

Mu, 2003, A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS, J. Control. Release, 86, 33, 10.1016/S0168-3659(02)00320-6

Feng, 2008, Nanoparticles of biodegradable polymers for cancer treatment, Biomaterials, 29, 4146, 10.1016/S0142-9612(08)00562-0